Akari Therapeutics (AKTX) Prepaid Assets (2014 - 2026)

Akari Therapeutics (AKTX) reported Prepaid Assets of $30000.0 for Q1 2026, down 95.22% on a YoY basis from $627000.0 in Q1 2025, and down 83.78% sequentially from $185000.0 in Q4 2025.

Akari Therapeutics (AKTX) Prepaid Assets (2014 - 2026) Analysis & Trends

Akari Therapeutics (AKTX) has 13 years of Prepaid Assets data on file, last reported at $30000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Prepaid Assets fell 95.22% year-over-year to $30000.0; the trailing twelve-month figure through Mar 2026 stood at $30000.0 (down 95.22% YoY), and the FY2025 full-year result was $185000.0, up 101.09% from the prior year.
  • Prepaid Assets eased to $30000.0 in Q1 2026, from $185000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $627000.0 in Q1 2025 to a low of $30000.0 in Q1 2026.
  • A 5-year average of $228545.5 and a median of $185000.0 in 2025 frame the typical range for Prepaid Assets.
  • Across the five-year window, Prepaid Assets jumped 375.53% in 2025 and tumbled 95.22% in 2026, its largest moves.
  • Tracing AKTX's Prepaid Assets over 5 years: stood at $465000.0 in 2022, then tumbled by 57.63% to $197000.0 in 2023, then tumbled by 53.3% to $92000.0 in 2024, then soared by 101.09% to $185000.0 in 2025, then slumped by 83.78% to $30000.0 in 2026.
  • Business Quant data shows AKTX's Prepaid Assets at $30000.0 in Q1 2026, $185000.0 in Q4 2025, and $53000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 30,000.00
Dec 31, 2025 185,000.00
Sep 30, 2025 53,000.00
Jun 30, 2025 447,000.00
Mar 31, 2025 627,000.00
Dec 31, 2024 92,000.00
Sep 30, 2024 92,000.00
Jun 30, 2024 94,000.00
Mar 31, 2024 232,000.00
Dec 31, 2023 197,000.00
Dec 31, 2022 465,000.00
Dec 31, 2021 2.17 Mn
Dec 31, 2020 229,200.00
Sep 30, 2020 1.35 Mn
Jun 30, 2020 1.68 Mn
Mar 31, 2020 1.83 Mn
Dec 31, 2019 712,975.00
Sep 30, 2019 1.06 Mn
Jun 30, 2019 1.75 Mn
Mar 31, 2019 1.89 Mn